]>
IRCT20210912052449N1 IRCT 2022-01-11 Shiraz University of Medical Sciences The effectiveness of cognitive-behavioral group therapy on patients with schizophrenia The effectiveness of cognitive-behavioral group therapy on improving metacognitive beliefs, insight and adherence of treatment and reducing pressure in caregivers of patients with schizophrenia 2021-09-23 anticipated 36 Complete https://irct.ir/trial/58705 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Schizophrenia. Intervention 1: Intervention group 1: In the intervention group, the treatment program will be performed by an experienced group therapist in seven sessions with 15 minutes of rest (three times a week) based on a treatment protocol adapted from Robert Paul Lieberman's 16-session community return program. This program is an "Independent and Social Life Skills" program developed by the Center for Psychiatric Rehabilitation Clinical Research at UCLA. Each session begins with an initial discussion and question and then continues for an hour and a half on the topic of the same discussion session. Topics discussed in each session include the following: Session 1: The nature of mental disorders, stigmatization and normalization, Session 2: Communication and expression skills, Session 3: Symptoms of the disorder and symptoms of recurrence, Session 4: Medication, Benefits and side effects, Session 5: Stress management skills, Session 6: Rehabilitation and self-care skills, Session 7: Preparation for discharge. Intervention 2: Intervention group 2: In order to evaluate the effect of the therapist's attention, the therapist's placebo group will watch documentaries without a psychological background for seven sessions in the presence of the therapist and will discuss the subject of the film. Intervention 3: Control group: The control group will also receive only their usual treatments, which include a visit to a psychiatrist. Yes - There is a plan to make this available What will be shared: By identifying individuals, information will only be published in groups When: 6 months after the end of the research To whom: The data will be available only for the Vice Chancellor for Research of Shiraz University of Medical Sciences Conditions: Only treatment planning for study participants Where to obtain: Principal Investigator How to obtain: After the individual application was approved by the Vice Chancellor for Research of Shiraz University of Medical Sciences Comments:
public Samad Fereidooni
Shiraz Psychiatric Hospital, Bajgah
Shiraz Iran (Islamic Republic of) 7144193355 +98 71 3260 5678 psysamadf@gmail.com Shiraz University of Medical Sciences scientific Samad Fereidooni
Shiraz Psychiatric Hospital, Bajgah
Shiraz Iran (Islamic Republic of) 7144193355 +98 71 3260 5678 psysamadf@gmail.com Shiraz University of Medical Sciences Iran (Islamic Republic of) Having diagnostic criteria for schizophrenia disorder, according to DSM 5 Age range between 18 and 50 years Having at least a middle school degree Not receiving electroconvulsive therapy (at least two months before and during hospitalization) Not receiving psychological treatments at the same time as entering the study or 3 months before entering the study Patient and family consent to participate in the study Living with a family member (at least three months before hospitalization) 18 years 50 years Both Patients who are in the acute phase of the disease Patients who are active substance abusers Having serious suicidal thoughts Having any serious medical condition (to prevents further treatment) Mental retardation Brain damage More than one group absence session Comorbidity of substance dependence disorder Comorbidity of other psychiatric disorders F20 Schizophrenia Rehabilitation Rehabilitation Rehabilitation Intervention group 1: In the intervention group, the treatment program will be performed by an experienced group therapist in seven sessions with 15 minutes of rest (three times a week) based on a treatment protocol adapted from Robert Paul Lieberman's 16-session community return program. This program is an "Independent and Social Life Skills" program developed by the Center for Psychiatric Rehabilitation Clinical Research at UCLA. Each session begins with an initial discussion and question and then continues for an hour and a half on the topic of the same discussion session. Topics discussed in each session include the following: Session 1: The nature of mental disorders, stigmatization and normalization, Session 2: Communication and expression skills, Session 3: Symptoms of the disorder and symptoms of recurrence, Session 4: Medication, Benefits and side effects, Session 5: Stress management skills, Session 6: Rehabilitation and self-care skills, Session 7: Preparation for discharge. Intervention group 2: In order to evaluate the effect of the therapist's attention, the therapist's placebo group will watch documentaries without a psychological background for seven sessions in the presence of the therapist and will discuss the subject of the film. Control group: The control group will also receive only their usual treatments, which include a visit to a psychiatrist. Metacognitive Beliefs Score in Adrienne Wells Metacognitive Beliefs Questionnaire. Timepoint: Assessment of metacognitive beliefs at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Adrienne Wells Metacognitive Beliefs Questionnaire. Insight level score based on Insight and Treatment Attitudes Questionnaire. Timepoint: Assessment of the patient's level of insight at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Insight and Treatment Attitudes Questionnaire. Score of adherence to treatment on the Medication Adherence Rating Scale. Timepoint: Assessment of patient adherence to treatment at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Medication Adherence Rating Scale. Care pressure level score based on Novak care pressure questionnaire. Timepoint: Assessment of the level of care pressure at the beginning of the study (before the intervention) and after the intervention and three months after the intervention. Method of measurement: Novak Care Pressure Questionnaire. Shiraz University of Medical Sciences Approved 2021-12-05 Ethics committee of Shiraz University of Medical Sciences Zand St., in front of Palestine St., the central building of Shiraz University of Medical Sciences shiraz Fars Iran (Islamic Republic of)